Viewing Study NCT01112228


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2025-12-26 @ 11:11 AM
Study NCT ID: NCT01112228
Status: COMPLETED
Last Update Posted: 2020-10-27
First Post: 2010-04-26
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Clinical Staging Tools for the Impacts of Obesity on Individuals
Sponsor: Imperial College London
Organization:

Study Overview

Official Title: Assessing Clinical Staging Tools for Tracking the Impacts of Obesity on Individuals
Status: COMPLETED
Status Verified Date: 2020-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: COST
Brief Summary: This study will assess various published staging tools to assess the health impacts of obesity on individuals. The aim is to identify benefits and drawbacks, and thus help Obesity Centres and GPs better assess obese individuals as well as better identify who benefits most from having weight loss treatment.
Detailed Description: This study will assess various published staging tools to assess the health impacts of obesity on individuals. The aim is to identify benefits and drawbacks, and thus help Obesity Centres and GPs better assess obese individuals as well as better identify who benefits most from having weight loss treatment

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: